MOA and Clinical Trial Data for Novel and Emerging Therapeutic Strategies for HCM: Can We Target Our Therapy?

Jan 16, 2023 | HCM

1b) Our expert (and returning @cardiomet_ce) author is Giuseppe Galati MD, MMSc in Heart Failure, FHFA, @GiuseppeGalati_ , Consultant #Cardiologist #HeartFailure & #Cardiomyopathies pic.twitter.com/W3CgRK0qAS— cardio-met (@cardiomet_CE) January 17, 2023 3) This...

HCM Prevalence, Pathophysiology, and Natural Course with and without Adequate Medical Treatment

Dec 21, 2022 | HCM

2a) This program is intended for #healthcare providers and is supported by an educational grant from Bristol-Myers Squibb. Statement of accreditation and faculty disclosures at https://t.co/gvXca4GHMU. FOLLOW US for the most timely expert education in #cardiometabolic...

Accredited by:

In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Learn More at AcademicCME.com

  • Menu:
  • Home
  • Faculty
  • Disclosures